Supplementary Figures 1-6, Supplementary Materials and Methods from Downregulation of miR-223 Expression Is an Early Event during Mammary Transformation and Confers Resistance to CDK4/6 Inhibitors in Luminal Breast Cancer

Abstract

<p>Supplementary Information, Methods and Figures. Supplementary Figure 1. Loss of miR-223 does not alter the murine mammary gland architecture; Supplementary Figure 2. miR-223 KO mice do not display any proliferative advantage during â^†16HER2-driven mammary tumorigenesis; Supplementary Figure 3. miR-223 WT and KO â^†16HER2 tumor-derived mammary epithelial cells (mMECs) display comparable tumorigenic potential; Supplementary Figure 4. miR-223 partially counteracts HER2-driven BC cell proliferation and 3D-organization; Supplementary Figure 5. miR-223 is rapidly down-modulated during cell transformation; Supplementary Figure 6. miR-223 is upregulated in response to anti-proliferative stimuli</p>